Fig. 3From: Breaking down the evidence for bevacizumab in advanced cervical cancer: past, present and futureGOG 240 study design. Abbreviations: GOG, Gynecologic Oncology Group; PS, performance status; m2: square meters, mg: milligram, IV: intravenous, Kg: kilogram. Figure 3 is from I. Diaz-Padilla et al. Critical Reviews in Oncology/Hematology 85 (2013) 303–314 [77] and is used with permission Back to article page